GlassScriptPhysician profile
Ashley Berish
NPI 1285167825
$3,725.82
in general payments reported to CMS, 2019-2025
24 companies · $226 in 2025
The $226 reported for 2025 was more than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $108 · 2021: $63.34 · 2022: $1,761 · 2023: $1,161 · 2024: $406 · 2025: $226.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,434 · Travel and Lodging: $336 · Gift: $22.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,434.04 |
| Travel and Lodging | $335.87 |
| Gift | $22.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $1,532.82 | 2022-2024 | Acessa Provu System |
| Intuitive Surgical, INC. | $960.63 | 2022-2023 | Da Vinci Surgical System |
| Mayne Pharma Commercial LLC | $251.00 | 2021-2025 | |
| Astellas Pharma US INC | $161.37 | 2023-2025 | Veozah |
| Biogen, INC. | $117.69 | 2024-2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $109.62 | 2021-2025 | |
| Mallinckrodt Enterprises LLC | $108.43 | 2019 | |
| Medtronic, INC. | $73.92 | 2022-2023 | Truclear |
| Pfizer INC. | $67.31 | 2024-2025 | |
| Coopersurgical, INC. | $49.49 | 2023-2025 | Paragard T 380a, Sos |
| Exeltis, USA INC. | $49.21 | 2023-2025 | Slynd |
| Myriad Women'S Health, INC. | $31.64 | 2023 | Myrisk |
| Shield Therapeutics INC | $29.80 | 2023-2024 | Accrufer |
| Becton, Dickinson and Company | $19.55 | 2024 | Bd Max System, Bd Max Instrument |
| Sumitomo Pharma America, INC. | $19.00 | 2025 | Myfembree |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $18.95 | 2022 | |
| Organon LLC | $18.75 | 2021 | |
| Axonics, INC. | $17.18 | 2024 | Axonics, Bulkamid |
| Glaxosmithkline, LLC. | $16.89 | 2021 | |
| Abbvie INC. | $16.62 | 2022 | |
| Gynesonics, INC. | $16.09 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Dexcom, INC. | $14.43 | 2024 | Dexcom G6 Transmitter |
| Meditrina | $13.02 | 2024 | |
| Therapeuticsmd, INC. | $12.41 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Berish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.